A dose escalation and cohort expansion study of the CDK9 inhibitor KB0742 in relapsed, refractory ovarian cancer and transcriptionally addicted relapsed or refractory solid tumors
CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要